Merus N.V. CS (MRUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRUS | AZN | AMGN | GILD | BMY |
| Company | Merus N.V. CS | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 96.86 | 207.30 | 357.46 | 142.38 | 59.79 |
| High | 96.86 | 207.30 | 357.46 | 142.38 | 59.80 |
| Low | 87.14 | 203.82 | 349.75 | 138.45 | 58.46 |
| Latest | 90.00 | 203.96 | 351.01 | 139.04 | 58.62 |
| Change | -6.92 | -1.03 | -4.59 | -3.05 | -0.85 |
| % Change | -7.14% | -0.50% | -1.29% | -2.15% | -1.43% |
| Volume | 2,728,600 | 1,325,883 | 1,222,064 | 2,619,760 | 5,733,831 |
| 20-Day Average Volume | 1,160,195 | 1,849,608 | 2,684,619 | 5,800,547 | 13,213,992 |
| Previous Close | 96.92 | 204.99 | 355.60 | 142.09 | 59.47 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 96.27 | 193.78 | 351.86 | 139.80 | 59.04 |
| 20-Day Raw Stochastic | 28.60% | 88.52% | 39.98% | 33.64% | 36.88% |
| 20-Day Relative Strength | 26.76 | 59.72 | 46.63 | 46.63 | 48.62 |
| Weighted Alpha | +65.99 | +53.51 | +23.05 | +32.80 | +21.56 |
| Today's Opinion | 64% Buy | 88% Buy | 40% Buy | 40% Buy | 48% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 56% Buy | 56% Buy | 64% Buy |
| Last Month's Opinion | 100% Buy | 64% Buy | 100% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.23% since 12/19/25 | +0.47% since 04/02/26 | +0.66% since 04/02/26 | -0.72% since 04/02/26 | -1.71% since 04/02/26 |
| Low | 87.14 on 12/29/25 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 57.65 on 04/07/26 |
| High | 97.02 on 12/22/25 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 59.79 on 04/10/26 |
| 1-Month | |||||
| %Chg | -6.39% since 11/28/25 | +4.85% since 03/10/26 | -6.71% since 03/10/26 | -6.63% since 03/10/26 | -2.58% since 03/10/26 |
| Low | 87.14 on 12/29/25 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 97.14 on 12/19/25 | 207.30 on 04/10/26 | 380.14 on 03/11/26 | 149.30 on 03/11/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -3.92% since 09/29/25 | +8.00% since 01/09/26 | +7.40% since 01/09/26 | +14.54% since 01/09/26 | +4.87% since 01/09/26 |
| Low | 87.14 on 12/29/25 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 97.14 on 12/19/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +69.84% since 06/27/25 | +20.93% since 10/10/25 | +20.71% since 10/10/25 | +18.37% since 10/10/25 | +33.26% since 10/10/25 |
| Low | 51.78 on 07/08/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 97.14 on 12/19/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,826,230 | 317,920,640 | 191,911,984 | 176,365,248 | 121,421,984 |
| Shares Outstanding, K | 75,847 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 36,130,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -215,330,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 12,150,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -95,520,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.06 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.23 on 10/31/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/26/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.30 | 16.01 | 17.37 | 9.63 |